Skip to content
HowShorted

Omeros Corporation short interest in 2021

In 2021, Omeros Corporation's disclosed short interest ran from 20.04% of shares outstanding on 15 Jan 2021 to 17.47% on 31 Dec 2021, a change of -2.57 percentage points. The year's high was 22.50% on 15 Apr 2021 and its low 15.81% on 30 Sep 2021, averaging 19.19% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 41.92 days on 14 May 2021. Full history: Omeros Corporation.

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Omeros Corporation in 2021

2021 in figures

Start of year
20.04% (15 Jan 2021)
End of year
17.47% (31 Dec 2021)
Change
-2.57 pp
High
22.50% (15 Apr 2021)
Low
15.81% (30 Sep 2021)
Average
19.19%
Highest days to cover
41.92 (14 May 2021)
SEC filings marked
8

Every report in 2021

Omeros Corporation short interest in 2021
SettlementShort interestDays to coverFilings since previous
15 Jan 202120.04%19.16
29 Jan 202120.11%13.10
12 Feb 202120.70%15.99
26 Feb 202120.27%22.38
15 Mar 202121.31%18.1610-K filed, results (8-K)
31 Mar 202121.15%27.58
15 Apr 202122.50%25.37
30 Apr 202121.39%24.54
14 May 202121.55%41.9210-Q filed, results (8-K)
28 May 202119.65%12.82
15 Jun 202119.73%25.77
30 Jun 202119.23%23.90
15 Jul 202118.29%25.50
30 Jul 202117.80%37.69
13 Aug 202117.95%24.2510-Q filed, results (8-K)
31 Aug 202117.18%28.89
15 Sep 202116.62%26.42
30 Sep 202115.81%17.78
15 Oct 202118.13%4.24
29 Oct 202118.80%5.11
15 Nov 202118.36%12.6810-Q filed, results (8-K)
30 Nov 202118.80%20.07
15 Dec 202117.61%4.27
31 Dec 202117.47%13.02

See also: Omeros Corporation's full history · most shorted US stocks of 2021 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.